Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash from Operations (2021 - 2025)

PAVmed (PAVM) has 5 years of Cash from Operations data on record, last reported at 896000.0 in Q3 2025.

  • For Q3 2025, Cash from Operations changed N/A year-over-year to 896000.0; the TTM value through Sep 2025 reached 3607000.0, changed N/A, while the annual FY2024 figure was 33600000.0, 35.43% up from the prior year.
  • Cash from Operations reached 896000.0 in Q3 2025 per PAVM's latest filing, up from 1178000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 48000.0 in Q4 2024 and bottomed at 22558000.0 in Q2 2022.
  • Average Cash from Operations over 5 years is 10665777.78, with a median of 11765000.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: tumbled 240.34% in 2022, then skyrocketed 100.4% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 16777000.0 in 2021, then dropped by 0.27% to 16823000.0 in 2022, then grew by 29.42% to 11874000.0 in 2023, then soared by 100.4% to 48000.0 in 2024, then tumbled by 1966.67% to 896000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 896000.0 in Q3 2025, 1178000.0 in Q2 2025, and 1581000.0 in Q1 2025.